drug
as of 2026-07-01GSK1018921
at a glance
small molecule
Pre-approval / investigational in the US
Developed by GlaxoSmithKline
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.
NCT00945503Phase 1Completed
First Time in Human Study With GSK1018921
NCT00527020Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication